KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Intangibles: 2018-2022

Historic Intangibles for Esperion Therapeutics (ESPR) over the last 2 years, with Dec 2022 value amounting to $56,000.

  • Esperion Therapeutics' Intangibles changed negligibly% to $56,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $56,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $56,000 for FY2022, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2022, Esperion Therapeutics' Intangibles is $56,000, which was down 0.00% from $56,000 recorded in Q4 2021.
  • Esperion Therapeutics' 5-year Intangibles high stood at $56,000 for Q1 2018, and its period low was $56,000 during Q1 2018.
  • Over the past 3 years, Esperion Therapeutics' median Intangibles value was $56,000 (recorded in 2022), while the average stood at $56,000.